Skip to content

Public FDA record

Z-1396-2024: OptiCross Coronary Imaging Catheter, REF H749518080120

Recall record Z-1396-2024 for Boston Scientific Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1396-2024
Company in FDA record
Boston Scientific Corporation
FDA classification date
Mar 28, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Certain batches of Opticross 40MHz Coronary Imaging Catheters manufactured using an incorrect voltage setting, which may have resulted in decreased image brightness.

Source facts

Action
Boston Scientific issued an Urgent Medical Device Removal notice to its consignees on 03/05/2024 via overnight delivery. The notice explained the issue, potential risk, and requested the consignee immediately discontinue use, segregate, and respond pending return of the device.
Initiated
2024-03-05
Root cause
Process control
Distribution
International distribution to the country of Japan.
Recall number
Z-1396-2024
Recall status
Open, Classified
CDRH record ID
206479
FDA classified
2024-03-28
Recall event number
94162

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗